On September 28, AmCham Healthcare Committee members met to discuss the application and effects of the new EU standards on safety features appearing on the packaging of medicinal products for human use. In particular, debates concerned the regime for notifying to the local authority the changes in barcodes for individual packs. The second subject on the agenda was the new draft governmental decision altering the rules for state registration of drugs’ prices, and its long-term impact for the physical and economical accessibility of qualitative drugs.
Please see more details in the presentation
Sun | Mon | Tue | Wed | Thu | Fri | Sat |
---|---|---|---|---|---|---|